Marshall Wace’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.82M Sell
121,006
-376,194
-76% -$26.5M 0.01% 1087
2025
Q4
$33.5M Buy
497,200
+103,445
+26% +$6.96M 0.03% 462
2025
Q3
$28.9M Buy
393,755
+4,624
+1% +$307K 0.03% 507
2025
Q2
$20.2M Sell
389,131
-74,477
-16% -$4.24M 0.02% 580
2025
Q1
$29.6M Buy
463,608
+459,182
+10,375% +$26.7M 0.04% 408
2024
Q4
$212K Buy
+4,426
New +$227K ﹤0.01% 2339
2024
Q2
Sell
-75,533
Closed -$3.07M 2704
2024
Q1
$3.07M Sell
75,533
-570,635
-88% -$21.4M ﹤0.01% 1184
2023
Q4
$23.9M Sell
646,168
-2,078,643
-76% -$78.3M 0.04% 425
2023
Q3
$104M Buy
2,724,811
+401,288
+17% +$16.4M 0.21% 92
2023
Q2
$83.8M Buy
2,323,523
+1,433,856
+161% +$48.9M 0.16% 137
2023
Q1
$34M Buy
+889,667
New +$41.7M 0.07% 300
2022
Q3
Sell
-110,861
Closed -$4.88M 3521
2022
Q2
$4.88M Buy
+110,861
New +$4.79M 0.01% 1358
2020
Q1
Sell
-8,317
Closed -$147K 1814
2019
Q4
$147K Buy
+8,317
New +$144K ﹤0.01% 1401
2019
Q3
Sell
-513,083
Closed -$8.81M 1773
2019
Q2
$8.81M Buy
513,083
+467,136
+1,017% +$7.54M 0.07% 319
2019
Q1
$740K Buy
+45,947
New +$744K 0.01% 1022

Other funds holding HALO

Marshall Wace's HALO Position: Q1 2026 in Review

Marshall Wace reduced its Halozyme (HALO) stake by 76% in Q1 2026, selling an estimated $26.5M and leaving 121,006 shares worth $7.82M. The position accounts for 0.01% of the portfolio, ranked #1087.

Marshall Wace first reported a position in HALO in Q1 2019 and has held it in 15 quarters since. The position peaked at $104M in Q3 2023. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Marshall Wace held 121,006 shares of Halozyme worth $7.82M as of Q1 2026.
  • Marshall Wace sold 376,194 Halozyme shares in Q1 2026, an estimated $26.5M.
  • Halozyme made up 0.01% of Marshall Wace's portfolio in Q1 2026, its #1087 holding.
  • Marshall Wace first reported a position in Halozyme in Q1 2019 and has held it in 15 quarters since.
  • Marshall Wace's Halozyme position peaked at $104M in Q3 2023.
  • 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.